NEUP Neuphoria Therapeutics Inc. - Common Stock
$3,95
Precio · Ago 19, 2026
Fundamentales a fecha de May 15, 2026
Rango 52S
$3–$21
4% of range
Calificación del Analista
HOLD
6 analysts
Precio Objetivo
$7
+77% upside
P/E (TTM)
-17.2
ROE
-2.3%
Margen de Beneficio Neto
-2.4%
NEUP Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$3.95
Capitalización Bursátil
$8M
P/E (TTM)
-17.2
BPA (TTM)
$-0.23
Ingresos (TTM)
$16M
Rendimiento div.
—
ROE
-2.3%
Deuda/Capital
—
Rango 52S
$3 – $21
NEUP Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$16M
2025-06-30
→
2025-06-30
BPA
$-0.23
2023-06-30
→
2025-06-30
Flujo de caja libre
—
Márgenes
-2.4%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
NEUP
Mediana de Pares
P/E (TTM)
-17.2
—
P/S (TTM) (P/V (TTM))
0.5
1.3
P/B (P/C)
0.4
0.7
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
NEUP
Mediana de Pares
Operating Margin (Margen Operativo)
-7.2%
—
Net Profit Margin (Margen de Beneficio Neto)
-2.4%
59.5%
ROA
-1.3%
-1353.2%
ROE
-2.3%
-910.3%
ROIC
-2.6%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
NEUP
Mediana de Pares
Current Ratio (Ratio corriente)
3.6
7.2
Quick Ratio (Ratio Rápido)
3.4
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
NEUP
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
NEUP
Mediana de Pares
NEUP Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
VENTA
6 analistas
- Compra fuerte 0 0,0%
- Compra 0 0,0%
- Mantener 3 50,0%
- Venta 1 16,7%
- Venta fuerte 2 33,3%
Precio objetivo a 12 meses
1 analistas · 2026-05-17
Mín
$7.00
Máx
$7.00
Objetivo mediano
$7.00
+77,2%
Objetivo medio
$7.00
+77,2%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-1.3%
Próximo informe
Sep 28, 2026
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de septiembre de 2026 | $-0.09 | $-0.57 | — |
| 31 de marzo de 2026 | $-0.09 | $-0.99 | 0.90% |
| 31 de diciembre de 2025 | $-0.77 | $-1.49 | 0.72% |
| 30 de septiembre de 2025 | $-4.41 | $-1.35 | -3.1% |
| 30 de junio de 2025 | $-5.79 | $-2.12 | -3.7% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| NEUP | $14M | -30.9 | — | -2.4% | -2.3% | — |
| PPCB | $48M | -0.3 | — | — | -1209.0% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 15
| Métrica | Tendencia | 2025 |
|---|---|---|
| Revenue | $16M | |
| R&D Expense | $9M | |
| SG&A Expense | $8M | |
| Operating Expenses | $17M | |
| Operating Income | $-1M | |
| Interest Income | $166.5K | |
| Other Non-op | $291.1K | |
| Pretax Income | $-838.0K | |
| Income Tax | $-468.4K | |
| Net Income | $-400.0K | |
| EPS (Basic) | $-0.23 | |
| EPS (Diluted) | $-0.23 | |
| Shares (Basic) | 1,622,924 | |
| Shares (Diluted) | 1,622,924 | |
| EBITDA | $-1M |
Balance general 19
| Métrica | Tendencia | 2025 |
|---|---|---|
| Cash & Equivalents | $14M | |
| Receivables | $11.9K | |
| Prepaid Expense | $740.2K | |
| Current Assets | $15M | |
| PP&E (Net) | $2.8K | |
| Goodwill | $9M | |
| Intangibles | $5M | |
| Total Assets | $29M | |
| Accounts Payable | $1M | |
| Current Liabilities | $4M | |
| Deferred Tax | $495.1K | |
| Total Liabilities | $10M | |
| Common Stock | $19 | |
| Paid-in Capital | $200M | |
| Retained Earnings | $-178M | |
| AOCI | $-3M | |
| Stockholders' Equity | $19M | |
| Liabilities + Equity | $29M | |
| Shares Outstanding | 1,978,460 |
Flujo de Efectivo 8
| Métrica | Tendencia | 2025 |
|---|---|---|
| D&A | $662.9K | |
| Stock-based Comp | $163.8K | |
| Deferred Tax | $-468.4K | |
| Operating Cash Flow | $77.2K | |
| Stock Issued | $2M | |
| Net Stock Activity | $2M | |
| Financing Cash Flow | $2M | |
| Net Change in Cash | $2M |
Rentabilidad 7
| Métrica | Tendencia | 2025 |
|---|---|---|
| Operating Margin | -7.2% | |
| Net Margin | -2.4% | |
| Pretax Margin | -5.3% | |
| EBITDA Margin | -7.2% | |
| ROA | -1.3% | |
| ROE | -2.3% | |
| ROIC | -2.6% |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 |
|---|---|---|
| Current Ratio | 3.6 | |
| Quick Ratio | 3.4 |
Eficiencia 2
| Métrica | Tendencia | 2025 |
|---|---|---|
| Asset Turnover | 0.6 | |
| Receivables Turnover | 225.4 |
Valoración (TTM) 9
| Métrica | Tendencia | 2025 |
|---|---|---|
| Revenue TTM | $16M | |
| Net Income TTM | $-400.0K | |
| Market Cap | $14M | |
| P/E | -30.9 | |
| P/S | 0.9 | |
| P/B | 0.7 | |
| P / Tangible Book | 2.5 | |
| P / Cash Flow | 181.9 | |
| Earnings Yield | -3.2% |
Estado de resultados 15
| Métrica | Tendencia | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $-13.3K | $15M | $662.7K | |
| R&D Expense | · | $697.7K | $4M | $4M | $2M | $2M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $1M | $3M | |
| Operating Expenses | $1M | $4M | $6M | $6M | $3M | $4M | |
| Operating Income | $-1M | $-4M | $-6M | $-6M | $12M | $-4M | |
| Interest Income | $186.2K | $167.3K | $142.0K | $87.0K | $12.7K | $30.6K | |
| Other Non-op | $671.8K | $6M | $-4M | $-3M | $-796.2K | $2M | |
| Pretax Income | $-539.9K | $2M | $-10M | $-9M | $11M | $-2M | |
| Income Tax | $-34.8K | $-34.8K | $-34.8K | $-266.6K | $-81.2K | $11.6K | |
| Net Income | $-505.1K | $2M | $-10M | $-9M | $11M | $-2M | |
| EPS (Basic) | $-0.09 | $0.41 | $-4.41 | $-4.93 | $6.55 | $-1.23 | |
| EPS (Diluted) | $-0.09 | $-0.77 | $-4.41 | $-4.37 | $6.55 | $-1.79 | |
| Shares (Basic) | 5,411,244 | 4,536,235 | 2,246,066 | -2,971,458 | 1,719,073 | 1,575,244 | |
| Shares (Diluted) | 5,411,244 | 4,536,235 | 2,246,066 | -2,971,458 | 1,719,073 | 1,575,244 | |
| EBITDA | $-1M | $-4M | $-6M | · | $12M | $-4M |
Balance general 21
| Métrica | Tendencia | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $22M | $14M | $14M | $17M | $4M | |
| Receivables | $2M | $1M | $1.8K | $11.9K | $24.6K | $35.6K | |
| Prepaid Expense | $611.9K | $27.0K | $222.3K | $740.2K | $20.9K | $18.5K | |
| Current Assets | $22M | $23M | $14M | $15M | $17M | $4M | |
| PP&E (Net) | · | · | $2.6K | $2.8K | $1.6K | $1.7K | |
| Goodwill | $9M | $9M | $9M | $9M | $8M | $8M | |
| Intangibles | $4M | $4M | $5M | $5M | $5M | $5M | |
| Total Assets | $35M | $37M | $27M | $29M | $31M | $18M | |
| Accounts Payable | $627.2K | $520.7K | $1M | $1M | $745.3K | $2M | |
| Current Liabilities | $2M | $3M | $5M | $4M | $2M | $2M | |
| Capital Leases | · | · | · | · | $19.3K | $49.8K | |
| Deferred Tax | $390.7K | $425.5K | $460.3K | $495.1K | $761.7K | $842.9K | |
| Other Non-current Liabilities | · | · | · | · | $3.6K | $3.4K | |
| Total Liabilities | $5M | $7M | $15M | $10M | $5M | $4M | |
| Common Stock | $54 | $54 | $23 | $19 | $19 | $16 | |
| Paid-in Capital | $218M | $218M | $204M | $200M | $199M | $198M | |
| Retained Earnings | $-187M | $-186M | $-188M | $-178M | $-169M | $-181M | |
| AOCI | $-2M | $-2M | $-3M | $-3M | $-4M | $-4M | |
| Stockholders' Equity | $29M | $30M | $13M | $19M | $26M | $14M | |
| Liabilities + Equity | $35M | $37M | $27M | $29M | $31M | $18M | |
| Shares Outstanding | 5,377,329 | 5,377,329 | 2,357,613 | 1,978,460 | 1,853,966 | 1,628,659 |
Flujo de Efectivo 8
| Métrica | Tendencia | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|
| D&A | $165.7K | $165.8K | $165.8K | $165.6K | $165.4K | $166.1K | |
| Stock-based Comp | $70.3K | $93.7K | $111.3K | $98.3K | $19.7K | $19.1K | |
| Restructuring | $42.4K | $1M | · | · | · | · | |
| Operating Cash Flow | $-3M | $-6M | $-4M | $-4M | $11M | $-3M | |
| Stock Issued | $0 | $15M | $3M | $704.7K | $823.6K | $0 | |
| Net Stock Activity | · | · | $3M | · | · | · | |
| Financing Cash Flow | $0 | $15M | $3M | $704.7K | $1M | $-111.6K | |
| Net Change in Cash | $-3M | $9M | $-560.5K | $-3M | $13M | $-4M |
Rentabilidad 7
| Métrica | Tendencia | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | 79.8% | -558.8% | |
| Net Margin | · | · | · | · | 75.1% | -293.2% | |
| Pretax Margin | · | · | · | · | 74.5% | -291.5% | |
| EBITDA Margin | · | · | · | · | 79.8% | -558.8% | |
| ROA | -1.5% | 6.8% | -39.4% | · | 73.3% | -21.4% | |
| ROE | -1.8% | 8.6% | -67.0% | · | 86.6% | -28.3% | |
| ROIC | -3.9% | -13.9% | -45.0% | · | 46.4% | -27.1% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 14.3 | 9.0 | 2.7 | · | 11.0 | 2.1 | |
| Quick Ratio | 13.9 | 9.0 | 2.7 | · | 11.0 | 2.1 |
Eficiencia 2
| Métrica | Tendencia | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 1.0 | 0.1 | |
| Receivables Turnover | · | · | · | · | 1219.9 | 37.3 |
Valoración (TTM) 7
| Métrica | Tendencia | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $3M | $1M | $-1M | · | $6M | $-10M | |
| Market Cap | $22M | $21M | $28M | · | $11M | $6M | |
| P/E | 3.2 | -9.2 | -43.7 | · | 4.4 | -0.3 | |
| P/B | 0.7 | 0.7 | 2.2 | · | 0.4 | 0.4 | |
| P / Tangible Book | 1.3 | 1.3 | · | · | 0.8 | 27.3 | |
| P / Cash Flow | · | · | -7.3 | · | · | · | |
| Earnings Yield | 31.4% | -10.8% | -2.3% | · | 22.7% | -307.6% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-06-30 | 2024-06-30 | 2023-06-30 | |
|---|---|---|---|
| Ingresos | $16M | — | — |
| Margen Operativo % | -7.2% | — | — |
| Beneficio neto | $-400.0K | $-15M | $-21M |
| EPS Diluido | $-0.23 | $-18.62 | $-0.02 |
Balance general
| 2025-06-30 | 2024-06-30 | 2023-06-30 | |
|---|---|---|---|
| Ratio corriente | 3.6 | 3.4 | — |
| Ratio Rápido | 3.4 | 3.3 | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 23 declarantes · $8.5M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 6 (0 vs trimestre anterior) | 3 (-4 vs trimestre anterior) | 7 (+3 vs trimestre anterior) | 1 (-1 vs trimestre anterior) | +231K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Lynx1 Capital Management LP | $3 825 183 | 875 328 | 45,15% | Acciones |
| AdvisorShares Investments LLC | $1 105 212 | 252 909 | 13,04% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $758 143 | 173 488 | 8,95% | Acciones |
| Shay Capital LLC | $680 942 | 155 822 | 8,04% | Acciones |
| Balyasny Asset Management L.P. | $621 536 | 142 228 | 7,34% | Acciones |
| CITADEL ADVISORS LLC | $317 083 | 72 559 | 3,74% | Acciones |
| Ikarian Capital, LLC | $207 326 | 47 443 | 2,45% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $177 269 | 40 565 | 2,09% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $147 732 | 33 806 | 1,74% | Acciones |
| ADAR1 Capital Management, LLC | $131 100 | 30 000 | 1,55% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $111 435 | 25 500 | 1,32% | Acciones |
| XTX Topco Ltd | $100 899 | 23 089 | 1,19% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $61 180 | 14 000 | 0,72% | Acciones |
| COMMONWEALTH EQUITY SERVICES, LLC | $49 040 | 11 222 | 0,58% | Acciones |
| NORTHERN TRUST CORP | $46 366 | 10 610 | 0,55% | Acciones |
| Merck & Co., Inc. | $43 818 | 10 027 | 0,52% | Acciones |
| VANGUARD GROUP INC | $42 959 | 11 072 | 0,51% | Acciones |
| JANE STREET GROUP, LLC | $35 729 | 8 176 | 0,42% | Acciones |
| UBS Group AG | $9 251 | 2 117 | 0,11% | Acciones |
| FNY Investment Advisers, LLC | $115 | 26 500 | 0,00% | Acciones |
| HRT FINANCIAL LP | $99 | 22 865 | 0,00% | Acciones |
| MORGAN STANLEY | $31 | 7 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $13 | 3 | 0,00% | Acciones |
Informantes de la empresa 5 insiders · 1 directivos · 5 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Spyros Papapetropoulos | President and CEO | 27 de agosto de 2025 A | — | 0 | 0 | $0 |
| Peter Miles Winston Davies | Consejero | 20 de enero de 2026 A | — | 0 | 0 | $0 |
| David Ian Wilson | Consejero | 20 de enero de 2026 A | — | 0 | 0 | $0 |
| Jane Ryan | Consejero | 20 de enero de 2026 A | — | 0 | 0 | $0 |
| Alan Fisher | Consejero | 20 de enero de 2026 A | — | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP, Weston Nichols ×6 presentaciones | 29 de diciembre de 2025 | 16,30% | Enmienda | — | SEC |
| Apeiron Investment Group Ltd., Apeiron Presight Capital Fund II, L.P., Presight Capital Management I, L.L.C., Fabian Hansen, Christian Angermayer ×3 presentaciones | 28 de enero de 2025 | 4,50% | Enmienda | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 2 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.